Relmada Therapeutics Inc logo

Relmada Therapeutics Inc

STU:4E2 (USA)  
€ 2.80 (+0.72%) Jun 21
At Loss
P/B:
1.27
Market Cap:
€ 85.40M ($ 91.68M)
Enterprise V:
€ 7.30M ($ 7.84M)
Volume:
-
Avg Vol (2M):
-
Trade In:

This is a preview!

Analysis and historical valuations for Apple Inc are shown here for you to look at this page's features.

Apple Inc Stock Intrinsic Values -